CLINICAL_TRIALS
trial_result
· 2026-03-20
Clinical Trial Update: Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases [NA]
Summary
This completed clinical trial evaluated blood-brain barrier disruption using MR-guided focused ultrasound in HER2-positive breast cancer patients with brain met…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: InSightec | Conditions: Breast Cancer, Brain Metastases | NA | Status: COMPLETED